Loading clinical trials...
Loading clinical trials...
A Phase II Study of Irinotecan/Cisplatin Plus Simvastatin in Chemo-naive Patients With Extensive Disease-Small Cell Lung Cancer
Conditions
Interventions
Irinotecan
Cisplatin
+1 more
Locations
1
South Korea
National Cancer Center, Korea
Goyang-si, Gyenggi, South Korea
Start Date
April 1, 2006
Primary Completion Date
November 1, 2009
Completion Date
May 1, 2010
Last Updated
June 19, 2013
NCT07190248
NCT06066138
NCT07485114
NCT05692635
NCT06305754
NCT07100080
Lead Sponsor
National Cancer Center, Korea
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions